NCT05105464: A Study to Investigate the Safety of SYHA1815 in Subjects With Unresectable Locally Advanced or Metastatic Solid Tumors |
|
|
| Recruiting | 1/2 | 97 | RoW | SYHA1815, SYHA1815 tablet | Shanghai Runshi Pharmaceutical Technology Co., Ltd, Jilin Provincial Tumor Hospital | Locally Advanced Unresectable Carcinoma | 09/23 | 09/23 | | |
